$ATOM
Atomera Inc Stock $atom

$atom Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000168316824002847 Filed on April 30, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$72.00K	$18.00K
YoY Change
Cost Of Revenue	$74.00K	$33.00K
YoY Change
Gross Profit	-$2.000K	-$15.00K
YoY Change
Gross Profit Margin	-2.78%	-83.33%
Selling, General & Admin	$2.039M	$2.161M
YoY Change	-5.95%	1.41%
% of Gross Profit
Research & Development	$2.589M	$2.858M
YoY Change	-18.89%	-5.86%
% of Gross Profit
Depreciation & Amortization	$294.0K	$298.0K
YoY Change	-5.16%	1390.0%
% of Gross Profit
Operating Expenses	$4.628M	$5.019M
YoY Change	-13.66%	-2.86%
Operating Profit	-$4.630M	-$5.034M
YoY Change	-13.62%	-2.57%
Interest Expense	$150.0K	$166.0K
YoY Change	48.51%	213.21%
% of Operating Profit
Other Income/Expense, Net	$269.0K	$46.00K
YoY Change	151.4%	-68.92%
Pretax Income	-$4.361M	-$4.822M
YoY Change	-15.35%	-3.93%
Income Tax
% Of Pretax Income
Net Earnings	-$4.361M	-$4.822M
YoY Change	-15.35%	-3.93%
Net Earnings / Revenue	-6056.94%	-26788.89%
Basic Earnings Per Share	-$0.16	-$0.19
Diluted Earnings Per Share	-$0.16	-$0.19
COMMON SHARES
Basic Shares Outstanding	26.89M shares	26.62M shares
Diluted Shares Outstanding	26.47M shares	26.04M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.29M	$19.26M
YoY Change	-23.27%	12.97%
Cash & Equivalents	$14.48M	$14.81M
Short-Term Investments	$3.804M	$4.458M
Other Short-Term Assets	$578.0K	$328.0K
YoY Change	-11.08%	8.25%
Inventory
Prepaid Expenses
Receivables	$6.000K	$0.00
Other Receivables	$74.00K	$73.00K
Total Short-Term Assets	$18.95M	$19.67M
YoY Change	-22.78%	13.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$75.00K	$3.164M
YoY Change	-98.28%	1967.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$105.0K	$105.0K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$2.922M	$3.269M
YoY Change	-34.4%	-31.61%
TOTAL ASSETS
Total Short-Term Assets	$18.95M	$19.67M
Total Long-Term Assets	$2.922M	$3.269M
Total Assets	$21.87M	$22.93M
YoY Change	-24.56%	3.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$646.0K	$601.0K
YoY Change	14.95%	42.08%
Accrued Expenses	$249.0K	$927.0K
YoY Change	-76.4%	283.06%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.386M	$1.357M
YoY Change	2.14%	9.44%
Total Short-Term Liabilities	$3.144M	$2.902M
YoY Change	5.72%	18.74%
LONG-TERM LIABILITIES
Long-Term Debt	$1.108M	$1.431M
YoY Change	-53.37%	-46.66%
Other Long-Term Liabilities	$137.0K	$194.0K
YoY Change	-65.75%	-59.16%
Total Long-Term Liabilities	$1.245M	$1.625M
YoY Change	-55.15%	-48.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.144M	$2.902M
Total Long-Term Liabilities	$1.245M	$1.625M
Total Liabilities	$4.389M	$4.527M
YoY Change	-23.67%	-19.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$212.3M	-$207.9M
YoY Change	9.72%	10.4%
Common Stock	$229.8M	$226.3M
YoY Change	6.02%	10.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.48M	$18.41M
YoY Change
Total Liabilities & Shareholders Equity	$21.87M	$22.93M
YoY Change	-24.56%	3.61%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$4.361M	-$4.822M
YoY Change	-15.35%	-3.93%
Depreciation, Depletion And Amortization	$294.0K	$298.0K
YoY Change	-5.16%	1390.0%
Cash From Operating Activities	-$3.164M	-$4.149M
YoY Change	-19.65%	-2.01%
INVESTING ACTIVITIES
Capital Expenditures	$6.000K	$0.00
YoY Change	100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$689.0K	$2.521M
YoY Change	-111.66%	-151.01%
Cash From Investing Activities	$683.0K	$2.521M
YoY Change	-111.55%	-150.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.159M	3.843M
YoY Change	-79.7%	2974.4%
NET CHANGE
Cash From Operating Activities	-3.164M	-4.149M
Cash From Investing Activities	683.0K	2.521M
Cash From Financing Activities	2.159M	3.843M
Net Change In Cash	-322.0K	2.215M
YoY Change	-140.97%	-124.43%
FREE CASH FLOW
Cash From Operating Activities	-$3.164M	-$4.149M
Capital Expenditures	$6.000K	$0.00
Free Cash Flow	-$3.170M	-$4.149M
YoY Change	-19.56%	-2.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
CY2024Q1	ATOM	Unbilled Contracts Receivable Current UnbilledContractsReceivableCurrent	0	usd
CY2023Q4	ATOM	Unbilled Contracts Receivable Current UnbilledContractsReceivableCurrent	550000	usd
CY2024Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	73000	usd
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	79000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	328000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	244000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	19665000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	20404000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	100000	usd
CY2024Q1	ATOM	Longterm Prepaid Maintenance And Supplies LongtermPrepaidMaintenanceAndSupplies	91000	usd
CY2023Q4	ATOM	Longterm Prepaid Maintenance And Supplies LongtermPrepaidMaintenanceAndSupplies	91000	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	459000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	517000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2622000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2903000	usd
CY2024Q1	us-gaap	Assets Assets	22934000	usd
CY2023Q4	us-gaap	Assets Assets	24029000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	601000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	618000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	210000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	222000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	454000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1382000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	263000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	264000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1357000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1328000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	17000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2902000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3814000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	194000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	295000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1431000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1750000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	4527000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5859000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	47500000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	47500000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26905000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26885000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26107000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26107000	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	27000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	26000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	226288000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	221229000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-207907000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-203085000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	18407000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18170000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22934000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24029000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	-0	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-15000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	0	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2858000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3036000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1811000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1742000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	350000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	389000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	5019000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	5167000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5034000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5167000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	205000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	199000	usd
CY2024Q1	ATOM	Accretion Income AccretionIncome	46000	usd
CY2023Q1	ATOM	Accretion Income AccretionIncome	2000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	39000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	53000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	212000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	148000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4822000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5019000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26038000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23660000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26038000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23660000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4822000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5019000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4823000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5021000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18170000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1024000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	86000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3950000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4822000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20314000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	927000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	39000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4822000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5019000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	58000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	52000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	281000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	291000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1024000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	927000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-46000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-3000	usd
CY2024Q1	ATOM	Increase Decrease In Unbilled Contracts Receivable IncreaseDecreaseInUnbilledContractsReceivable	-550000	usd
CY2023Q1	ATOM	Increase Decrease In Unbilled Contracts Receivable IncreaseDecreaseInUnbilledContractsReceivable	-0	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-12000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	46000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	84000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-168000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-114000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	26000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-12000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	69000	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-928000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-675000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-102000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-44000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	17000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4149000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4234000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15000	usd
CY2024Q1	ATOM	Purchase Of Availableforsale Securities PurchaseOfAvailableforsaleSecurities	1479000	usd
CY2023Q1	ATOM	Purchase Of Availableforsale Securities PurchaseOfAvailableforsaleSecurities	4942000	usd
CY2024Q1	ATOM	Maturity Of Availableforsale Securities MaturityOfAvailableforsaleSecurities	4000000	usd
CY2023Q1	ATOM	Maturity Of Availableforsale Securities MaturityOfAvailableforsaleSecurities	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2521000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4957000	usd
CY2024Q1	ATOM	Proceeds From At The Market Sale Of Stock ProceedsFromAtTheMarketSaleOfStock	3950000	usd
CY2023Q1	ATOM	Proceeds From At The Market Sale Of Stock ProceedsFromAtTheMarketSaleOfStock	274000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	86000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	39000	usd
CY2024Q1	ATOM	Payments Of Principal For Financing Lease PaymentsOfPrincipalForFinancingLease	193000	usd
CY2023Q1	ATOM	Payments Of Principal For Financing Lease PaymentsOfPrincipalForFinancingLease	188000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3843000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	125000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2215000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-9066000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12591000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21184000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14806000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12118000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	26000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	53000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_803_eus-gaap--NatureOfOperations_zXQ2B50Bihvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_825_zfqjStxqgW07">NATURE OF OPERATIONS</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera Incorporated (“Atomera” or the “Company”) was incorporated in the state of Delaware in March 2007 under the name MEARS Technologies, Inc. and is engaged in the development, commercialization and licensing of proprietary processes and technologies for the semiconductor industry. On January 12, 2016, the Company changed its name to Atomera Incorporated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera is an early-stage company, having only recently begun limited revenue-generating activities, and is devoting substantially all its efforts toward technology research and development and to commercially licensing its technology to designers and manufacturers of integrated circuits.</p>
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	19300000	usd
CY2024Q1	ATOM	Working Capital WorkingCapital	16800000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	17000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4290000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3956000	shares
CY2024Q1	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	Effective May 1, 2023, the Company leased an additional 404 square feet at its Tempe office location under an amendment to its current lease. The monthly rent payment increased from $1,277 per month to $2,365 per month and the increased rent under the amended lease is accounted for as a modification to the lease under ASC 842 at the time of commencement.
CY2024Q1	us-gaap	Lessee Operating Lease Option To Terminate LesseeOperatingLeaseOptionToTerminate	The Company terminated its office lease in Cambridge, Massachusetts as of March 31, 2023. The cost of the lease was $2,942 per month.
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	281000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	291000	usd
CY2024Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	39000	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	53000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	320000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	344000	usd
CY2024Q1	ATOM	Fixed Lease Costs FixedLeaseCosts	66000	usd
CY2023Q1	ATOM	Fixed Lease Costs FixedLeaseCosts	62000	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	261000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	297000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	327000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	359000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	110000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	56000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	219000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	241000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0550	pure
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0525	pure
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y10M24D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1400000	shares
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1024000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	927000	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-002847-index-headers.html	Edgar Link	pending
0001683168-24-002847-index.html	Edgar Link	pending
0001683168-24-002847.txt	Edgar Link	pending
0001683168-24-002847-xbrl.zip	Edgar Link	pending
atom-20240331.xsd	Edgar Link	pending
atomera_ex3101.htm	Edgar Link	pending
atomera_ex3102.htm	Edgar Link	pending
atomera_ex3201.htm	Edgar Link	pending
atomera_i10q-033124.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
atom-20240331_cal.xml	Edgar Link	unprocessable
atom-20240331_lab.xml	Edgar Link	unprocessable
atom-20240331_def.xml	Edgar Link	unprocessable
atom-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
atomera_i10q-033124_htm.xml	Edgar Link	completed
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ATOM
Atomera Inc Stock $atom

2024 Q2 Form 10-Q Financial Statement

#000168316824002847 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATOM Atomera Inc Stock $atom

2024 Q2 Form 10-Q Financial Statement

#000168316824002847 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATOM
Atomera Inc Stock $atom